1887
  1. Home
  2. A-Z Publications
  3. Qatar Medical Journal
  4. Volume 2024, Issue 3
  5. Article
Volume 2024, Issue 3
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Background: Thyroid cancer (TC) is becoming more prevalent in Saudi Arabia, currently ranking among the top three cancers affecting women. Despite its rising prevalence, there has been limited assessment of the factors influencing the survival rate (SR) among the Saudi population over an extended period. Therefore, this study aims to address this critical gap in knowledge by identifying the factors affecting the SR of TC, comparing the SR with previous studies, and exploring potential areas for improving the SR of patients.

Methods: A retrospective study analyzed secondary data from patients diagnosed with TC, as recorded in the King Abdulaziz Medical City Cancer Registry in Riyadh, Saudi Arabia, over 10 years from 2009 to 2018.

Results: Of the total 665 TC cases, the mean age at diagnosis was 46.2 years (±SD 16), and most patients were women (78.5%), with the majority being under 50 years old. The most common type of cancer was papillary thyroid carcinoma, comprising 88.6% of all TCs. Over half of the cases were localized to one of the lobes of the thyroid gland, with almost equal frequency between the two lobes. The 5-year SR of localized papillary thyroid carcinoma reached 96.5%, in contrast to the extremely low SR of anaplastic thyroid carcinoma, where most patients died within a few months of the diagnosis. Factors such as morphology, tumor extension, male gender, and age at diagnosis significantly impacted patient survival, as analyzed by the Kaplan–Meier test ( < 0.001). Compared to other types of cancer, those with anaplastic thyroid carcinoma had a lower SR.

Conclusion: The SR of TC patients is predicted by factors such as their age, morphological type, and the presence of distant metastasis.

© 2024 Bawazir, Alhalafi, Al-Aidaross, Jazieh, Khan, Licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/qmj.2024.44
2024-09-16
2024-09-26
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2024/3/qmj.2024.44.html?itemId=/content/journals/10.5339/qmj.2024.44&mimeType=html&fmt=ahah

References

  1. IARC. Cancer Today: Age-Standardized Rate (World) per 100 000, Incidence, Both sexes, in 2022 for Thyroid Cancer Lyon/France: International Agency for research on Cancer/VVorld Health Organization; 2024. Available from: https://gco.iarc.fr/today/en/dataviz/bars?mode=population&cancers=32
     [Google Scholar]
  2. Flemban AF, Kabrah S, Alahmadi H, Alqurashi RK, Turaes AS, Almaghrabi R, et al.. Patterns of thyroid cancer mortality and incidence in Saudi Arabia: A 30-year study Diagnostics. 2022; 12:(11):2716https://doi.org/10.3390/diagnosticsl2112716
     [Google Scholar]
  3. Alotaibi RM, Rezk HR, Juliana CI, Guure C. Breast cancer mortality in Saudi Arabia: Modelling observed and unobserved factors. PLoS One. 2018; 13:(10):e0206148https://doi.Org/10.1371/journal.pone.0206148
     [Google Scholar]
  4. Hussain F, Iqbal S, Mehmood A, Bazarbashi S, ElHassan T, Chaudhri N. Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000-2010. Hematol Oncol Stem Cell Ther. 2013; 6:(2):58-64https://doi.org/10.1016/j.hemonc.2013.05.004
     [Google Scholar]
  5. IARC. Data visualization tools for exploring the global cancer burden in 2022. Factsheets Lyon: International Agency for research on Cancer World Health Organization; 2024. Available from: https://gco.iarc.fr/today/en
     [Google Scholar]
  6. SHC. Cancer Incidence Report In Kingdom of Saudi Arabia 2018. Riyadh: Ministry of Health/Saudi Health Council; 2022. Available from: https://shc.gov;sa/Arabic/NCC/Activities/AnnualReports/2018.pdf
     [Google Scholar]
  7. NCI. Population-based Cancer Survival Statistics Overview USA: National Cancer Institute; 2023. Available from: https://surveillan.ce.cancer.gov/survival/
     [Google Scholar]
  8. CR/UK. Cancer in the UK 2019. cruk.org: Cancer Research UK; 2020. Available from: https://www.cancerresearchuk.org/sites/default/files/state_of_the_nation_april_2019.pdf
     [Google Scholar]
  9. NCI. Surveillance Epidemiology and End Results (SEER) Program. Population Estimates Used in NCI’s SEER* Stat Software: National Cancer Institute; 2018. Available from: https://seer.cancer.gov/
     [Google Scholar]
  10. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020; 70:(1):7-30https://doi.org/10.3322/caac.21590
     [Google Scholar]
  11. ONS. Cancer registration statistics, England. 2017 UK: Office for National Statistics; 2017. Available from: https://www.ons.gov;uk/
     [Google Scholar]
  12. AG/CA. Cancer in Australia statistics Australian Australian Government; 2022. Available from: https://www.canceraustralia.gov.au/impacted-cancer/what-cancer/cancer-australia-statistics
     [Google Scholar]
  13. NCI. Surveillance Epidemiology and End Results (SEER) Program. Population Estimates Used in NCI’s SEER* Stat Software: National Cancer Institute Bethesda, MD; 2018. Available from: https://seer.cancer.gov/
     [Google Scholar]
  14. Jung CK, Bychkov A, Kakudo K. Update from the 2022 world health organization classification of thyroid tumors: A standardized diagnostic approach. Endocrinol Metab. 2022; 37:(5):703-l8. https://doi:10.3803/EnM.2022.1553
     [Google Scholar]
  15. LSHTM. CONCORD Programme. London: London School of Hygiene and Tropical Medicine; 2024. Available from: https://csg.lshtm.ac.uk/research/themes/concord-programme/
     [Google Scholar]
  16. ASCO. Thyroid Cancer: Survivorship USA: American Society of Clinical Oncology; 2023. Available from: https://www.cancer.net/cancer-types/thyroid-cancer/survivorship
     [Google Scholar]
  17. ACS. Early Detection, Diagnosis, and Staging: Thyroid Cancer Survival Rates, by Type and Stage: American Cancer Society; 2022. Available from: https://www.cancer.org/cancer/thyroid-cancer/detection-diagnosis-staging/survival-rates.html
     [Google Scholar]
  18. CRUK. Survival for thyroid cancer. London: Cancer Research; 2021. Available from: https://www.cancerresearchuk.org/about-cancer/thyroid-cancer/survival
     [Google Scholar]
  19. Borges AKdM, Ferreira JD, Koifman S, Koifman RJ. Differentiated thyroid carcinoma: A 5-year survival study at a referral hospital in Brazil. Rev Saude Publica. 2019; 53:106. https://doi.org/10.11606/S1518-8787.2019053001496
     [Google Scholar]
  20. Davies L, Welch HG. Thyroid cancer survival in the United States: Observational data from 1973 to 2005. Arch Otolaryngol Head Neck Surg. 2010; 136:(5):440-4https://doi.org/10.1001/archot0.2010.55
     [Google Scholar]
  21. Guevara M, Molinuevo A, Salmeron D, Marcos-Gragera R, Carulla M, Chirlaque M-D, et al.. Cancer survival in adults in Spain: A populationbased study of the Spanish network of cancer registries (REDECAN). Cancers. 2022; 14:(10):2441https://doi.org/10.3390/cancersl4102441
     [Google Scholar]
  22. Aseafan M, Devol E, AlAhwal M, Souissi R, Sindi R, AlEid H, et al.. Population-based survival for cancer patients in Saudi Arabia for the years 2005-2009. Sci Rep. 2022; 12:(l):l-9https://doi.org/10.1038/S41598-021-04374-6
     [Google Scholar]
  23. Kauffmann RM, Hamner JB, Ituarte PH, Yim JH. Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: Should there be three age categories for staging? BMC Cancer. 2018; 18:(l):l-l0https://doi.org/10.1186/s12885-018-4181-4
     [Google Scholar]
  24. Almubarak AA, Albkiry YA, Alsalem AA, Saad MAE. The association of low socioeconomic status with advanced stage thyroid cancer. J Taibah Univ Med Sci. 2021; 16:(4):482-90https://doi.org/10.1016/jtumed.2021.04.006
     [Google Scholar]
  25. ACS. Thyroid Cancer Survival Rates, by Type and Stage USA: American Cancer Society; 2023. Available from: https://www.cancer.org/cancer/types/thyroid-cancer/detection-diagnosis-staging/survival-rates.html
     [Google Scholar]
  26. Kunjumohamed FP, Al Rawahi A, Al Busaidi NB, Al Musalhi HN. Disease-free survival of patients with differentiated thyroid cancer: A study from a tertiary center in Oman. Oman Med J. 202l; 36:(2):e246https://doi.org/10.5001/omj.2021.54
     [Google Scholar]
  27. Al-Zahrani A, Ravichandran K. Epidemiology of thyroid cancer: A review with special reference to Gulf Cooperation Council (GCC) states. Gulf J Oncolog. 2007; 2:17-28.
    [Google Scholar]
  28. Hameed M, Garcia G, Yaseen L, Sohail I, Effendi I, Amin A, et al.. Cancer survivorship in gulf countries: An updated systematic review. Blood. 2023; 142:7276. https://doi.org/10.1182/blood-2023-189517
     [Google Scholar]
  29. Ragazzi M, Ciarrocchi A, Sancisi V, Gandolfi G, Bisagni A, Piana S. Update on anaplastic thyroid carcinoma: Morphological, molecular, and genetic features of the most aggressive thyroid cancer. Int J Endocrinol 2014;. 2014. https://doi.org/10.1155/2014/790834
     [Google Scholar]
/content/journals/10.5339/qmj.2024.44
Loading
Predictors of thyroid cancer survival in Saudi Arabia: A retrospective 10-year analysis
Qatar Medical Journal 2024, 44 (2024); https://doi.org/10.5339/qmj.2024.44
/content/journals/10.5339/qmj.2024.44
/content/journals/10.5339/qmj.2024.44
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): follicular thyroid carcinoma, papillary thyroid carcinoma, Survival rate and thyroid cancer

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error